Avanir Pharmaceuticals, Inc. (AVNR) Posts Better-Than-Expected Q1 Results
Tweet
Share
E-mailGet Alerts AVNR Hot Sheet
Price: $16.96 --0%
Financial Fact:
Net product sales: 26.54M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Net product sales: 26.54M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $7.2 million versus the consensus estimate of $6.49 million.
For earnings history and earnings-related data on Avanir Pharmaceuticals, Inc. (AVNR) click here.
For earnings history and earnings-related data on Avanir Pharmaceuticals, Inc. (AVNR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
- Globant (GLOB) Misses Q2 EPS by 10c, Offers Guidance
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
